Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDCD1LG2 | Q9BQ51 | 2/20 | 0.35 |
| ▸ | CD274 | Q9NZQ7 | 2/20 | 0.35 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.34 |
| ▸ | DPP4 | P27487 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.33 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.33 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.33 |
| ▸ | MME | P08473 | 1/20 | 0.33 |
| ▸ | VSIR | Q9H7M9 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6010210 | 1.00 | PDCD1LG2 (0.35) | PDCD1LG2CD274OR51E2DPP4TP53 | |
| SCHEMBL28325810 | 0.88 | DPP4 (0.39) | OR51E2DPP4TP53ADRB2ADRB1 | |
| SCHEMBL28325811 | 0.88 | DPP4 (0.39) | OR51E2DPP4TP53ADRB2ADRB1 | |
| Glycerin SCHEMBL1944312 | 0.86 | DPP4 (0.38) | OR51E2DPP4TP53ADRB2ADRB1 | |
| SCHEMBL6010401 | 0.85 | ALDH1A1 (0.49) | DPP4MMEALDH1A1CA2CA1 | |
| SCHEMBL6010410 | 0.85 | ALDH1A1 (0.49) | DPP4MMEALDH1A1CA2CA1 | |
| SCHEMBL23961406 | 0.81 | CYP2D6 (0.44) | TP53MMECYP2D6ALDH1A1CYP2C19 | |
| SCHEMBL21290998 | 0.81 | CYP2D6 (0.44) | TP53MMECYP2D6ALDH1A1CYP2C19 | |
| SCHEMBL14930537 | 0.81 | CYP2D6 (0.44) | TP53MMECYP2D6ALDH1A1CYP2C19 | |
| SCHEMBL11739951 | 0.79 | KDM4E (0.47) | PDCD1LG2CD274OR51E2TP53MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060018864-A1 | Cosmetic preparation containing glycerylamino acid derivative | SEIWA KASEI COMPANY, LIMITED (JP) | 2006-01-26 | — | — | US | disclosed |
| EP-1584320-A1 | COSMETIC PREPARATION CONTAINING GLYCERYLAMINO ACID DERIVATIVE | Seiwa Kasei Company, Limited (JP) | 2005-10-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060018864-A1 | Cosmetic preparation containing glycerylamino acid derivative | GLA, GPKOW, CUTA | PDCD1LG2 2072/4885CD274 2066/4885OR51E2 2335/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.